{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:56:10Z","timestamp":1782284170318,"version":"3.54.5"},"reference-count":209,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["400616\/2022-0"],"award-info":[{"award-number":["400616\/2022-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["303781\/2020-3"],"award-info":[{"award-number":["303781\/2020-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpain.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T17:41:18Z","timestamp":1711302078000},"page":"104514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Voltage-gated Calcium Channels as Potential Therapeutic Targets in Migraine"],"prefix":"10.1016","volume":"25","author":[{"given":"Juliana G.","family":"Chichorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-9110","authenticated-orcid":false,"given":"Eder","family":"Gambeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darciane F.","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib1","article-title":"Revisiting migraine: the evolving pathophysiology and the expanding management armamentarium","volume":"15","author":"Gawde","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2024.03.010_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase-by-phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.jpain.2024.03.010_bib4","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"issue":"10258","key":"10.1016\/j.jpain.2024.03.010_bib6","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/a-1942-6823","article-title":"The epidemiology of primary headache disorders","volume":"42","author":"Kopel","year":"2022","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ncl.2023.01.002","article-title":"Migraine and the gender divide","volume":"41","author":"Vanood","year":"2023","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","article-title":"Migraine","volume":"8","author":"Ferrari","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"17","key":"10.1016\/j.jpain.2024.03.010_bib10","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10194-022-01518-5","article-title":"The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence","volume":"23","author":"Gollion","year":"2022","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib12","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s12035-023-03300-3","article-title":"Glia signaling and brain microenvironment in migraine","volume":"60","author":"Amani","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-022-01538-1","article-title":"Migraine attacks are of peripheral origin: the debate goes on","volume":"24","author":"Do","year":"2023","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-023-01569-2","article-title":"Shared and independent roles of CGRP and PACAP in migraine pathophysiology","volume":"24","author":"Kuburas","year":"2023","journal-title":"J Headache Pain"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-020-02161-7","article-title":"Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators","volume":"127","author":"Messlinger","year":"2020","journal-title":"J Neural Transm ((Vienna))"},{"issue":"16","key":"10.1016\/j.jpain.2024.03.010_bib16","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.3390\/ijms241612553","article-title":"The role of glial cells in different phases of migraine: lessons from preclinical studies","volume":"24","author":"Vila-Pueyo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10194-023-01572-7","article-title":"Cytokines in primary headache disorders: a systematic review and meta-analysis","volume":"24","author":"Musubire","year":"2023","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/WCO.0000000000000310","article-title":"The migraine postdrome","volume":"29","author":"Bose","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"52","key":"10.1016\/j.jpain.2024.03.010_bib21","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","article-title":"Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists","volume":"275","author":"Yamaguchi","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib22","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1523\/JNEUROSCI.15-04-02995.1995","article-title":"Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons","volume":"15","author":"Randall","year":"1995","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1152\/jn.2001.85.2.816","article-title":"Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents","volume":"85","author":"Bell","year":"2001","journal-title":"J Neurophysiol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0026-895X(25)13240-9","article-title":"Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels","volume":"44","author":"Adams","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"47","key":"10.1016\/j.jpain.2024.03.010_bib25","doi-asserted-by":"crossref","first-page":"12566","DOI":"10.1021\/bi00210a003","article-title":"Toxityping rat brain calcium channels with omega-toxins from spider and cone snail venoms","volume":"32","author":"Adams","year":"1993","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.jpain.2024.03.010_bib26","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1021\/bi00317a001","article-title":"Purification and sequence of a presynaptic peptide toxin from Conus geographus venom","volume":"23","author":"Olivera","year":"1984","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.jpain.2024.03.010_bib27","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1073\/pnas.89.11.5058","article-title":"Molecular cloning of the alpha-1 subunit of an omega-conotoxin-sensitive calcium channel","volume":"89","author":"Dubel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"10.1016\/j.jpain.2024.03.010_bib28","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-3495(01)75681-0","article-title":"Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Ca(V)2.3) calcium channels","volume":"81","author":"Bourinet","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.jpain.2024.03.010_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1113\/jphysiol.1987.sp016864","article-title":"Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones","volume":"394","author":"Fox","year":"1987","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","article-title":"Neuronal voltage-gated calcium channels: structure, function, and dysfunction","volume":"82","author":"Simms","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41467-023-36260-2","article-title":"Molecular insights into the gating mechanisms of voltage-gated calcium channel Ca(V)2.3","volume":"14","author":"Gao","year":"2023","journal-title":"Nat Commun"},{"issue":"7787","key":"10.1016\/j.jpain.2024.03.010_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","article-title":"Cryo-EM structures of apo and antagonist-bound human Ca(v)3.1","volume":"576","author":"Zhao","year":"2019","journal-title":"Nature"},{"issue":"7870","key":"10.1016\/j.jpain.2024.03.010_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-021-03699-6","article-title":"Structure of human Ca(v)2.2 channel blocked by the painkiller ziconotide","volume":"596","author":"Gao","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0896-6273(95)90100-0","article-title":"Ca2+ channel selectivity at a single locus for high-affinity Ca2+ interactions","volume":"15","author":"Ellinor","year":"1995","journal-title":"Neuron"},{"issue":"6451","key":"10.1016\/j.jpain.2024.03.010_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/366158a0","article-title":"Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels","volume":"366","author":"Yang","year":"1993","journal-title":"Nature"},{"issue":"7481","key":"10.1016\/j.jpain.2024.03.010_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature12775","article-title":"Structural basis for Ca2+ selectivity of a voltage-gated calcium channel","volume":"505","author":"Tang","year":"2014","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.jpain.2024.03.010_bib39","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1523\/JNEUROSCI.16-16-04983.1996","article-title":"The alpha 1E calcium channel exhibits permeation properties similar to low-voltage-activated calcium channels","volume":"16","author":"Bourinet","year":"1996","journal-title":"J Neurosci"},{"issue":"6615","key":"10.1016\/j.jpain.2024.03.010_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/385442a0","article-title":"Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit","volume":"385","author":"Zamponi","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib41","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200095","article-title":"The life cycle of voltage-gated Ca(2+) channels in neurons: an update on the trafficking of neuronal calcium channels","volume":"5","author":"Ferron","year":"2021","journal-title":"Neuronal Signal"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/febs.15759","article-title":"Voltage-gated calcium channel nanodomains: molecular composition and function","volume":"289","author":"Gandini","year":"2022","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1152\/physrev.00029.2007","article-title":"Supramolecular assemblies and localized regulation of voltage-gated ion channels","volume":"89","author":"Dai","year":"2009","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuron.2013.02.032","article-title":"Competition between alpha-actinin and Ca(2)(+)-calmodulin controls surface retention of the L-type Ca(2)(+) channel Ca(V)1.2","volume":"78","author":"Hall","year":"2013","journal-title":"Neuron"},{"issue":"28","key":"10.1016\/j.jpain.2024.03.010_bib45","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1523\/JNEUROSCI.1712-04.2004","article-title":"Alternative splicing as a molecular switch for Ca2+\/calmodulin-dependent facilitation of P\/Q-type Ca2+ channels","volume":"24","author":"Chaudhuri","year":"2004","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cardiores.2005.06.024","article-title":"Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles","volume":"68","author":"Liao","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"6670","key":"10.1016\/j.jpain.2024.03.010_bib47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/36110","article-title":"Molecular characterization of a neuronal low-voltage-activated T-type calcium channel","volume":"391","author":"Perez-Reyes","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib48","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/hmg\/ddl068","article-title":"A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies","volume":"15","author":"Zhong","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1074\/jbc.M111.268722","article-title":"Alternative splicing at C terminus of Ca(V)1.4 calcium channel modulates calcium-dependent inactivation, activation potential, and current density","volume":"287","author":"Tan","year":"2012","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2013.06.008","article-title":"Control of neuronal voltage-gated calcium ion channels from RNA to protein","volume":"36","author":"Lipscombe","year":"2013","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1874467208666150507103215","article-title":"Calcium channel CaValpha(1) splice isoforms - tissue specificity and drug action","volume":"8","author":"Lipscombe","year":"2015","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib52","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bbamem.2012.09.018","article-title":"Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences","volume":"1828","author":"Lipscombe","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0166-2236(88)90194-4","article-title":"Multiple types of neuronal calcium channels and their selective modulation","volume":"11","author":"Tsien","year":"1988","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/8070","article-title":"Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels","volume":"2","author":"Bourinet","year":"1999","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","article-title":"Regulation of neuronal T-type calcium channels","volume":"30","author":"Iftinca","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib56","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.410250610","article-title":"Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons","volume":"25","author":"Coulter","year":"1989","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib57","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1523\/JNEUROSCI.12-10-03804.1992","article-title":"A novel T-type current underlies prolonged Ca(2+)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus","volume":"12","author":"Huguenard","year":"1992","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib58","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1523\/JNEUROSCI.14-09-05485.1994","article-title":"Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects","volume":"14","author":"Huguenard","year":"1994","journal-title":"J Neurosci"},{"issue":"35","key":"10.1016\/j.jpain.2024.03.010_bib59","doi-asserted-by":"crossref","first-page":"33001","DOI":"10.1074\/jbc.M104387200","article-title":"Identification of inactivation determinants in the domain IIS6 region of high voltage-activated calcium channels","volume":"276","author":"Stotz","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-3495(01)76008-0","article-title":"Molecular determinants of inactivation within the I-II linker of alpha1E (CaV2.3) calcium channels","volume":"80","author":"Berrou","year":"2001","journal-title":"Biophys J"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib61","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1073\/pnas.94.4.1512","article-title":"Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit","volume":"94","author":"Herlitze","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2006.08.023","article-title":"Determinants of the differential gating properties of Cav3.1 and Cav3.3 T-type channels: a role of domain IV?","volume":"143","author":"Hamid","year":"2006","journal-title":"Neuroscience"},{"issue":"Pt 1","key":"10.1016\/j.jpain.2024.03.010_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1469-7793.2001.0035m.x","article-title":"The amino side of the C-terminus determines fast inactivation of the T-type calcium channel alpha1G","volume":"530","author":"Staes","year":"2001","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib64","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0006-3495(01)76100-0","article-title":"Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties","volume":"80","author":"Chemin","year":"2001","journal-title":"Biophys J"},{"issue":"11","key":"10.1016\/j.jpain.2024.03.010_bib65","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn959","article-title":"Calcium-dependent inactivation of neuronal calcium channels","volume":"3","author":"Budde","year":"2002","journal-title":"Nat Rev Neurosci"},{"issue":"6732","key":"10.1016\/j.jpain.2024.03.010_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/20194","article-title":"Ca2+\/calmodulin binds to and modulates P\/Q-type calcium channels","volume":"399","author":"Lee","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0896-6273(00)80709-6","article-title":"Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels","volume":"22","author":"Peterson","year":"1999","journal-title":"Neuron"},{"issue":"5155","key":"10.1016\/j.jpain.2024.03.010_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.7832825","article-title":"Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission","volume":"264","author":"Wheeler","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jpain.2024.03.010_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.68274","article-title":"GABA(B) receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals","volume":"10","author":"Bhandari","year":"2021","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib70","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/nn.3563","article-title":"Differential triggering of spontaneous glutamate release by P\/Q-, N- and R-type Ca2+ channels","volume":"16","author":"Ermolyuk","year":"2013","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium-permeable ion channels in pain signaling","volume":"94","author":"Bourinet","year":"2014","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13041-022-00923-w","article-title":"Central and peripheral contributions of T-type calcium channels in pain","volume":"15","author":"Harding","year":"2022","journal-title":"Mol Brain"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system-40 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpain.2024.03.010_bib75","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2010.10.032","article-title":"Role for voltage gated calcium channels in calcitonin gene-related peptide release in the rat trigeminovascular system","volume":"172","author":"Amrutkar","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib76","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.bjp.0705456","article-title":"Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism","volume":"140","author":"Akerman","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"Pt 1","key":"10.1016\/j.jpain.2024.03.010_bib77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1469-7793.2001.t01-1-00035.x","article-title":"Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse","volume":"536","author":"Borgland","year":"2001","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib78","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1152\/jn.1999.81.3.1123","article-title":"Voltage-dependent sodium and calcium currents in acutely isolated adult rat trigeminal root ganglion neurons","volume":"81","author":"Kim","year":"1999","journal-title":"J Neurophysiol"},{"issue":"11","key":"10.1016\/j.jpain.2024.03.010_bib79","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.neuron.2022.03.003","article-title":"Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine","volume":"110","author":"Yang","year":"2022","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib80","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/j.pain.0000000000002651","article-title":"3.2 calcium channels contribute to trigeminal neuralgia","volume":"163","author":"Gambeta","year":"2022","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib81","article-title":"Efficacy of (S)-Lacosamide in preclinical models of cephalic pain","volume":"1","author":"Moutal","year":"2016","journal-title":"Pain Rep"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/19336950.2020.1859248","article-title":"Trigeminal neuropathic pain is alleviated by inhibition of Ca(v)3.3 T-type calcium channels in mice","volume":"15","author":"Montera","year":"2021","journal-title":"Channels (Austin)"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib83","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1074\/jbc.M605248200","article-title":"Molecular basis of Ca(v)2.3 calcium channels in rat nociceptive neurons","volume":"282","author":"Fang","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib84","article-title":"Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling","volume":"4","author":"Xiao","year":"2008","journal-title":"Mol Pain"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3959(00)00439-5","article-title":"Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission","volume":"91","author":"Ulrich-Lai","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0022034520950296","article-title":"CGRP modulates orofacial pain through mediating neuron-glia crosstalk","volume":"100","author":"Liang","year":"2021","journal-title":"J Dent Res"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2004.08.054","article-title":"Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat","volume":"135","author":"Shields","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.03.010_bib88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1113\/jphysiol.1989.sp017566","article-title":"Calcium channels in isolated rat dorsal horn neurones, including labelled spinothalamic and trigeminothalamic cells","volume":"411","author":"Huang","year":"1989","journal-title":"J Physiol"},{"issue":"1-3","key":"10.1016\/j.jpain.2024.03.010_bib89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2011.04.058","article-title":"Tyramine reduces glycinergic transmission by inhibiting presynaptic Ca(2+) channels in the rat trigeminal subnucleus caudalis","volume":"664","author":"Choi","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-2982.2004.00656.x","article-title":"Effects of N-, P\/Q- and L-type calcium channel blockers on nociceptive neurones of the trigeminal nucleus with input from the dura","volume":"24","author":"Ebersberger","year":"2004","journal-title":"Cephalalgia"},{"issue":"1-2","key":"10.1016\/j.jpain.2024.03.010_bib91","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pain.2009.07.038","article-title":"Electrophysiological and morphological properties of neurons in the substantia gelatinosa of the mouse trigeminal subnucleus caudalis","volume":"146","author":"Davies","year":"2009","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib92","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1074\/jbc.M114.548990","article-title":"Calcium channel alpha2delta1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.jpain.2024.03.010_bib93","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpain.2019.08.012","article-title":"Calcium channel alpha2delta1 subunit mediates secondary orofacial hyperalgesia through PKC-TRPA1\/Gap junction signaling","volume":"21","author":"Cui","year":"2020","journal-title":"J Pain"},{"issue":"13","key":"10.1016\/j.jpain.2024.03.010_bib94","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/03331024221112998","article-title":"KCl-induced repetitive cortical spreading depression inhibiting trigeminal neuronal firing is mediated by 5-HT(1B\/1D) and opioid receptors","volume":"42","author":"Supronsinchai","year":"2022","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(02)01120-5","article-title":"Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression","volume":"334","author":"Richter","year":"2002","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib96","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4522(99)00446-7","article-title":"Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P\/Q type calcium channels","volume":"95","author":"Ayata","year":"2000","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib97","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(04)00085-6","article-title":"A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression","volume":"41","author":"van den Maagdenberg","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib98","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/chan.5.2.14149","article-title":"Role of different voltage-gated Ca2+ channels in cortical spreading depression: specific requirement of P\/Q-type Ca2+ channels","volume":"5","author":"Tottene","year":"2011","journal-title":"Channels (Austin)"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib99","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","article-title":"Glutamate and its receptors as therapeutic targets for migraine","volume":"15","author":"Hoffmann","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051228","article-title":"Could the new anti-CGRP monoclonal antibodies be effective in migraine aura? Case reports and literature review","volume":"11","author":"Albanese","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231212895","article-title":"Targeting CGRP pathways and aura: a peripheral site with a central effect","volume":"43","author":"Al-Karagholi","year":"2023","journal-title":"Cephalalgia"},{"issue":"46","key":"10.1016\/j.jpain.2024.03.010_bib102","doi-asserted-by":"crossref","first-page":"18985","DOI":"10.1073\/pnas.1215435109","article-title":"Critical role of calcitonin gene-related peptide receptors in cortical spreading depression","volume":"109","author":"Tozzi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib103","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0006-8993(00)02527-0","article-title":"Alpha-eudesmol, a P\/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion","volume":"873","author":"Asakura","year":"2000","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00001756-200103260-00048","article-title":"N- and L- but not P\/Q-type calcium channels contribute to neuropeptide release from rat skin in vitro","volume":"12","author":"Kress","year":"2001","journal-title":"Neuroreport"},{"issue":"13","key":"10.1016\/j.jpain.2024.03.010_bib105","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1177\/0333102418786261","article-title":"Current understanding of trigeminal ganglion structure and function in headache","volume":"39","author":"Messlinger","year":"2019","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib106","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1460-9568.2006.04742.x","article-title":"Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons","volume":"23","author":"Bellamy","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib107","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1471-4159.2006.04161.x","article-title":"Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons","volume":"99","author":"Buldyrev","year":"2006","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib108","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s10194-023-01644-8","article-title":"Mode and site of action of therapies targeting CGRP signaling","volume":"24","author":"Labastida-Ram\u00edrez","year":"2023","journal-title":"J Headache Pain"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","article-title":"Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management","volume":"10","author":"Russell","year":"2011","journal-title":"Lancet Neurol"},{"issue":"329","key":"10.1016\/j.jpain.2024.03.010_bib110","article-title":"Zebrafish as a model system for the study of severe Ca(V)2.1 (alpha(1A)) channelopathies","volume":"12","author":"Tyagi","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib111","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","article-title":"Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4","volume":"87","author":"Ophoff","year":"1996","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib112","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00424-020-02396-z","article-title":"Rare CACNA1A mutations leading to congenital ataxia","volume":"472","author":"Izquierdo-Serra","year":"2020","journal-title":"Pflugers Arch"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib113","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1523\/JNEUROSCI.19-05-01610.1999","article-title":"Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine","volume":"19","author":"Hans","year":"1999","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/chan.3.2.7932","article-title":"Ca(V)2.1 P\/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies","volume":"3","author":"Adams","year":"2009","journal-title":"Channels (Austin)"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib115","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2009.01.027","article-title":"Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice","volume":"61","author":"Tottene","year":"2009","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib116","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.pain.2013.03.038","article-title":"Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice","volume":"154","author":"Chanda","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib117","first-page":"99","article-title":"Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1","volume":"119","author":"Eikermann-Haerter","year":"2009","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib118","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bbamem.2012.11.012","article-title":"Calcium channels and migraine","volume":"1828","author":"Pietrobon","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jpain.2024.03.010_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.892820","article-title":"Investigation of CACNA1I Cav3.3 dysfunction in hemiplegic migraine","volume":"15","author":"Maksemous","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib120","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1007\/s12035-023-03255-5","article-title":"Whole exome sequencing of hemiplegic migraine patients shows an increased burden of missense variants in CACNA1H and CACNA1I genes","volume":"60","author":"Maksemous","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib121","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","article-title":"Diagnosis and management of migraine in ten steps","volume":"17","author":"Eigenbrodt","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib122","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-2982.2008.01546.x","article-title":"Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2024.03.010_bib123","first-page":"Cd008041","article-title":"Aspirin with or without an antiemetic for acute migraine headaches in adults","volume":"4","author":"Kirthi","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib124","first-page":"Cd008039","article-title":"Ibuprofen with or without an antiemetic for acute migraine headaches in adults","volume":"2013","author":"Rabbie","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib125","first-page":"Cd008783","article-title":"Diclofenac with or without an antiemetic for acute migraine headaches in adults","volume":"2","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","article-title":"Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache","volume":"20","author":"Steiner","year":"2019","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib127","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0333102411433042","article-title":"Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study","volume":"32","author":"Lant\u00e9ri-Minet","year":"2012","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib129","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1503\/cmaj.221607","article-title":"Pharmacologic prevention of migraine","volume":"195","author":"Tzankova","year":"2023","journal-title":"Cmaj"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212785","article-title":"Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis","volume":"14","author":"Jackson","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2024.03.010_bib131","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1526-4610.2001.01154-2.x","article-title":"Antiepileptic drugs: how they work in headache","volume":"41","author":"Cutrer","year":"2001","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11940-019-0559-0","article-title":"Other preventive anti-migraine treatments: ACE inhibitors, ARBs, calcium channel blockers, serotonin antagonists, and NMDA receptor antagonists","volume":"21","author":"Rau","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"5222","key":"10.1016\/j.jpain.2024.03.010_bib133","article-title":"Tricyclic antidepressants and headaches: systematic review and meta-analysis","volume":"341","author":"Jackson","year":"2010","journal-title":"Bmj"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib134","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of action of onabotulinumtoxinA in chronic migraine: a narrative review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib136","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib137","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","article-title":"The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy","volume":"15","author":"Raffaelli","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib138","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1007\/s10072-022-06184-8","article-title":"Gepants - a long way to cure: a narrative review","volume":"43","author":"Altamura","year":"2022","journal-title":"Neurol Sci"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12121612","article-title":"Gepants for acute and preventive migraine treatment: a narrative review","volume":"12","author":"Rissardo","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.jpain.2024.03.010_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174902","article-title":"Small molecule CGRP receptor antagonists for the preventive treatment of migraine: a review","volume":"922","author":"Dos Santos","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib141","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.0306147101","article-title":"Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B\/1D receptor agonists","volume":"101","author":"Levy","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib142","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1523\/JNEUROSCI.19-09-03423.1999","article-title":"Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug","volume":"19","author":"Durham","year":"1999","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0704709","article-title":"Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery","volume":"136","author":"Akin","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib144","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0333102412451356","article-title":"The complex actions of sumatriptan on rat dural afferents","volume":"32","author":"Harriott","year":"2012","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2012.04.016","article-title":"Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres","volume":"63","author":"Baillie","year":"2012","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jpain.2024.03.010_bib146","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/molpharm.121.000419","article-title":"Serotonin-mediated activation of serotonin receptor type 1 oppositely modulates voltage-gated calcium channel currents in rat sensory neurons innervating hindlimb muscle","volume":"101","author":"Anselmi","year":"2022","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib147","first-page":"10","article-title":"Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons","volume":"2","author":"Morikawa","year":"2006","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2024.03.010_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.10.001","article-title":"Regulation of voltage gated calcium channels by GPCRs and post-translational modification","volume":"32","author":"Huang","year":"2017","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib149","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF00175798","article-title":"Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels","volume":"337","author":"Tytgat","year":"1988","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(91)90606-V","article-title":"Flunarizine inhibits a high-threshold inactivating calcium channel (N-type) in isolated hippocampal neurons","volume":"549","author":"Tytgat","year":"1991","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib151","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib152","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0197-0186(86)90079-3","article-title":"Interactions of verapamil, D 600, flunarizine and nifedipine with cerebral histamine-receptors","volume":"9","author":"Taylor","year":"1986","journal-title":"Neurochem Int"},{"issue":"2-3","key":"10.1016\/j.jpain.2024.03.010_bib153","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(91)90526-V","article-title":"Interaction of flunarizine with dopamine D2 and D1 receptors","volume":"197","author":"Ambrosio","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib154","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1526-4610.1981.hed2106235.x","article-title":"A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine","volume":"21","author":"Louis","year":"1981","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0303-8467(84)90273-7","article-title":"Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo","volume":"86","author":"Frenken","year":"1984","journal-title":"Clin Neurol Neurosurg"},{"issue":"Suppl 2","key":"10.1016\/j.jpain.2024.03.010_bib156","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/03331024850050S225","article-title":"Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation","volume":"5","author":"Mentenopoulos","year":"1985","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.jpain.2024.03.010_bib157","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1526-4610.1991.hed3110650.x","article-title":"Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability","volume":"31","author":"S\u00f8rensen","year":"1991","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib158","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1526-4610.1991.hed3109613.x","article-title":"Flunarizine in migraine prophylaxis: an Indian trial","volume":"31","author":"Thomas","year":"1991","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib159","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1526-4610.1992.hed3209461.x","article-title":"Flunarizine in migraine: a double-blind placebo-controlled study (in a Saudi population)","volume":"32","author":"Al Deeb","year":"1992","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","article-title":"Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily","volume":"22","author":"Diener","year":"2002","journal-title":"Cephalalgia"},{"issue":"Suppl 2","key":"10.1016\/j.jpain.2024.03.010_bib161","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/03331024850050S233","article-title":"Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine","volume":"5","author":"Pini","year":"1985","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib162","first-page":"119","article-title":"Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study","volume":"134","author":"Paterna","year":"1990","journal-title":"Clin Ter"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130733","article-title":"Comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache","volume":"10","author":"Jackson","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jpain.2024.03.010_bib164","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/brain\/awac264","article-title":"Vestibular migraine treatment: a comprehensive practical review","volume":"145","author":"Smyth","year":"2022","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib166","first-page":"670","article-title":"Guideline for primary care management of headache in adults","volume":"61","author":"Becker","year":"2015","journal-title":"Can Fam Physician"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib167","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1055\/s-0042-1755320","article-title":"Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II","volume":"80","author":"Santos","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"issue":"17","key":"10.1016\/j.jpain.2024.03.010_bib168","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of\u00a0Neurology\u00a0and\u00a0the\u00a0American\u00a0Headache\u00a0Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib169","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231183166","article-title":"The effect of blood pressure lowering medications on the prevention of episodic migraine: a systematic review and meta-analysis","volume":"43","author":"Carcel","year":"2023","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3949\/ccjm.73.9.793","article-title":"Migraine prophylaxis: who, why, and how","volume":"73","author":"Loj","year":"2006","journal-title":"Cleve Clin J Med"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib171","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neurol.2021.07.006","article-title":"Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: pharmacological treatment","volume":"177","author":"Ducros","year":"2021","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib172","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1468-2982.1986.0604229.x","article-title":"Contingent negative variation and efficacy of beta-blocking agents in migraine","volume":"6","author":"Schoenen","year":"1986","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib173","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1468-2982.2007.01377.x","article-title":"Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study","volume":"27","author":"Siniatchkin","year":"2007","journal-title":"Cephalalgia"},{"issue":"Pt 1","key":"10.1016\/j.jpain.2024.03.010_bib174","first-page":"86","article-title":"Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?","volume":"128","author":"Shields","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jpain.2024.03.010_bib175","first-page":"463","article-title":"Phosphorylation of Ser1928 mediates the enhanced activity of the L-type Ca2+ channel Cav1.2 by the \u03b22-adrenergic receptor in neurons","volume":"10","author":"Qian","year":"2017","journal-title":"Sci\u00a0Signal"},{"issue":"5527","key":"10.1016\/j.jpain.2024.03.010_bib176","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.293.5527.98","article-title":"A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2","volume":"293","author":"Davare","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib177","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1113\/jphysiol.2014.284208","article-title":"Noradrenaline upregulates T-type calcium channels in rat pinealocytes","volume":"593","author":"Yu","year":"2015","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib178","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib179","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1997.00550210071015","article-title":"A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura","volume":"54","author":"Kaniecki","year":"1997","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jpain.2024.03.010_bib180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1526-4610.1996.3609547.x","article-title":"Divalproex sodium in headache: literature review and clinical guidelines","volume":"36","author":"Silberstein","year":"1996","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib181","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1997.1702093.x","article-title":"Possible mechanisms of valproate in migraine prophylaxis","volume":"17","author":"Cutrer","year":"1997","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib182","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bjp.0706290","article-title":"Topiramate inhibits trigeminovascular activation: an intravital microscopy study","volume":"146","author":"Akerman","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib183","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.wnr.0000175250.33159.a9","article-title":"Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura","volume":"16","author":"Akerman","year":"2005","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib184","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ana.20778","article-title":"Suppression of cortical spreading depression in migraine prophylaxis","volume":"59","author":"Ayata","year":"2006","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib185","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-2982.2008.01682.x","article-title":"Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine","volume":"28","author":"Martella","year":"2008","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib186","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.0013-9580.2005.35304.x","article-title":"Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels","volume":"46","author":"Kuzmiski","year":"2005","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.jpain.2024.03.010_bib187","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40263-021-00834-9","article-title":"Indirect comparison of topiramate and monoclonal antibodies against CGRP or its receptor for the prophylaxis of episodic migraine: a systematic review with meta-analysis","volume":"35","author":"Overeem","year":"2021","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib188","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/nedt.2006.2.3.261","article-title":"Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability","volume":"2","author":"D'Amico","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib189","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2014.11.004","article-title":"Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example","volume":"16","author":"Dodick","year":"2015","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib191","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pain.2006.09.012","article-title":"Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A","volume":"125","author":"Jakubowski","year":"2006","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib192","first-page":"Cd011616","article-title":"Botulinum toxins for the prevention of migraine in adults","volume":"6","author":"Herd","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.jpain.2024.03.010_bib193","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1590\/0004-282X20130066","article-title":"Latin American consensus on guidelines for chronic migraine treatment","volume":"71","author":"Giacomozzi","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"issue":"11","key":"10.1016\/j.jpain.2024.03.010_bib194","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0000000000008095","article-title":"Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"J Headache Pain"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib196","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.abb.2012.05.016","article-title":"Inhibitory effect of botulinum toxin type A on the NANC system in rat respiratory models of neurogenic inflammation","volume":"524","author":"Chien","year":"2012","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib197","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1039\/C7IB00144D","article-title":"Bioreactor model of neuromuscular junction with electrical stimulation for pharmacological potency testing","volume":"9","author":"Charoensook","year":"2017","journal-title":"Integr Biol (Camb)"},{"issue":"1-2","key":"10.1016\/j.jpain.2024.03.010_bib198","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpain.2024.03.010_bib199","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.jpain.2024.03.010_bib201","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jpain.2024.03.010_bib202","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2147\/DDDT.S256814","article-title":"Botulinum toxin type A possibly affects Ca(v)3.2 calcium channel subunit in rats with spinal cord injury-induced muscle spasticity","volume":"14","author":"Ma","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jpain.2024.03.010_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.871187","article-title":"Medical cannabis for the treatment of migraine in adults: a review of the evidence","volume":"13","author":"Okusanya","year":"2022","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.jpain.2024.03.010_bib204","first-page":"409","article-title":"Cannabis guidelines","volume":"21","author":"Kennedy Sheldon","year":"2017","journal-title":"Clin J Oncol Nurs"},{"issue":"6","key":"10.1016\/j.jpain.2024.03.010_bib205","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/head.12570","article-title":"Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it's been \u2026","volume":"55","author":"Baron","year":"2015","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.jpain.2024.03.010_bib206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s10194-023-01589-y","article-title":"Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine","volume":"24","author":"Greco","year":"2023","journal-title":"J Headache Pain"},{"issue":"22","key":"10.1016\/j.jpain.2024.03.010_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.jpain.2024.03.010_bib208","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.1074\/jbc.M707104200","article-title":"Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol","volume":"283","author":"Ross","year":"2008","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jpain.2024.03.010_bib209","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/bph.16035","article-title":"Differential regulation of Ca(v) 3.2 and Ca(v) 2.2 calcium channels by CB(1) receptors and cannabidiol","volume":"180","author":"Harding","year":"2023","journal-title":"Br J Pharmacol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024004334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024004334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T02:58:01Z","timestamp":1754017081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590024004334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":209,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526590024004334"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2024.03.010","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voltage-gated Calcium Channels as Potential Therapeutic Targets in Migraine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"104514"}}